Xue Yin
Associate Chief Physician，Assistant Professor，
Department of Ophthalmology, The First Affiliated Hospital, Soochow University
E-mail：yinxuescu@suda.edu.cn
Biography:
With over 20 peer-reviewed publications as first or corresponding author in esteemed SCI-indexed journals—including Advanced Materials, Investigative Ophthalmology & Visual Science, Acta Ophthalmologica, Frontiers in Oncology, Graefe’s Archive for Clinical and Experimental Ophthalmology, Ocular Immunology and Inflammation, and BMC Ophthalmology— she maintains a strong academic record. One publication in Acta Ophthalmologica was distinguished as a Top Downloaded Paper. Her research program centers on clinical and foundational investigations in glaucoma, alongside pioneering applications of optical coherence tomography (OCT/OCTA) in ophthalmic science. As a Postdoctoral Fellow at the Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, she developed nanoformation strategies for glaucoma-related optic neuroprotection and engineered bifunctional peptide carriers for targeted protein delivery in treating neovascular choroidal disorders.
She has secured and led 7 competitive research grants, including the National Natural Science Foundation of China (Youth Program) and the Jiangsu Provincial Natural Science Foundation (Youth Program). Her work on OCT/OCTA earned the Second Prize of the Jiangsu Provincial Medical New Technology Introduction Award and the First Prize of the Suzhou Municipal Medical New Technology Introduction Award.
Research Interests:
glaucoma-related optic neuroprotection
pioneering applications of optical coherence tomography (OCT/OCTA) in ophthalmic science
Selected Publications:
1. Yuheng Cao, Xue Yin,* Lanrong Wu, et al. High-Efficiency Ocular Delivery of Brain-Derived Neurotrophic Factor and Oligomycin for Neuroprotection in Glaucoma. Adv. Mater. 2025, 2500623. (Co-corresponding author)
2. Zhou C, Lu Y, Ge L, Xin C, Yin X. Type 2 Uveal Effusion Syndrome with Psoriasis Vulgaris: A Case Report. Ocul Immunol Inflamm. 2025;33(8):1890-1893. (corresponding author)
3. Ge LY, Tian X, Guo HM, Yin X. Secondary childhood glaucoma in neurofibromatosis type 1: an unusual corneal leukoma case report. Front Oncol. 2024;14:1469969. (corresponding author)
4. Ge LY, Wu TH, Liu YQ, Jiang C, Yin X. Management of experimental trabeculectomy filtering blebs via crosslinking of the scleral flap inhibited vascularization. Graefes Arch Clin Exp Ophthalmol. 2024;262(5):1507-1517. (corresponding author)
5. Xue Y, Qinhua C. Short-Term Efficacy in Polypoidal Choroidal Vasculopathy Patients Treated With Intravitreal Aflibercept or Conbercept. Front Med (Lausanne). 2022;9:835255. (First Author)
6. Yin X, Cai Q. Branch retina vein occlusion combined with angle-closure glaucoma is associated with a mutation in BEST1: a case report. BMC Ophthalmol. 2022;22(1):288. (First Author)
7. Yin X, Zhang B, Chen L, Xia W, Liu G, Zhu X, Ren C, Liu W, Lu P*. Essential Contribution of Macrophage Tie2 Signaling in a Murine Model of Laser-induced Choroidal Neovascularization. Sci Rep, 2020, 10(1): 9613. (First Author)
8. Yin X, Li J, Zhang B, Lu P. Association of glaucoma with risk of retinal vein occlusion: A meta-analysis. Acta Ophthalmol. 2019;97(7):652-659. (First Author)
9. Yin X, Cai Q, Song R, He X, Lu P. Relationship between filtering bleb vascularization and surgical outcomes after trabeculectomy: an optical coherence tomography angiography study. Graefes Arch Clin Exp Ophthalmol. 2018;256(12):2399-2405. (First Author)
10. Yin X, Sun H, Yu D, Liang Y, Yuan Z*, Ge Y*; Hydroxycamptothecin Induces Apoptosis of Human Tenon’s Capsule Fibroblasts by Activating the PERK Signaling Pathway. Invest Ophthalmol Vis Sci, 2013, 54(7): 4749-4758. (First Author)
